Implant Sciences Cp (IMSC) 0.7200 $IMSC
Implant Sciences Announces Results of 2015 Annual Shareholder Meeting
PR Newswire - Tue Jul 07, 10:36AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it held its annual shareholders meeting on July 1, 2015 at its headquarters in Wilmington, MA. At this meeting, the company's shareholders approved each proposal presented, including the election of the Director nominees to the Board of Directors. The Board and Implant Sciences' management believes this outcome conveys investor confidence in the current direction of the company.
In the Latest in a Series of Wins, Finland Airports Select Implant Sciences' QS-B220
PR Newswire - Tue Jun 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 58 of its QS-B220 desktop explosives trace detectors to Finnish Airports. The systems are scheduled to be deployed within the next several months.
Implant Sciences' QS-B220 Wins GSN Award for "Best Security Checkpoint"
PR Newswire - Thu Jun 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced today its QS-B220 desktop explosives and drugs trace detector has won the 2015 GSN Airport/Seaport/Border Security Award for "Best Security Checkpoint" (persons, baggage, parcels). The QS-B220 was also a finalist in two other categories: "Best Explosives/Narcotics/Contraband Detection" and "Best Cargo/Vehicle Screening".
Up to 304 Additional QS-B220s Sold to French Airports as Implant Sciences Deepens its Foothold in EU
PR Newswire - Thu Jun 11, 8:30AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed a contract for up to 304 of its QS-B220 desktop explosives trace detectors across 17 regional airports in France. The first 106 units are committed to being delivered over the next several months. Additional units are expected to be delivered through fiscal year 2016 and 2017. The sale was made through the Company's in-country, full-service distributor, Hi-Tech Detection Systems (HTDS).
Four Major Airports in Poland Join Other European Airports in Selecting Implant Sciences' QS-B220 Trace Detectors to Meet European Security Regulations
PR Newswire - Thu Jun 04, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 16 of its QS-B220 desktop explosives trace detectors to four major international airports in Poland.
Implant Sciences Signs Deal for Up to $5 million with Ryan Security Technologies Ltd. to Expand Sales in China
PR Newswire - Mon Jun 01, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed an exclusive distribution agreement, worth up to $5 million, with Ryan Security Technologies Ltd. to manage sales and service of its products throughout all of China.
Another Major International European Airport Selects Implant Sciences' QS-B220
PR Newswire - Tue May 19, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 20 of its QS-B220 desktop explosives trace detectors into Belgium for aviation security. Shipment of these units is already underway and is expected to be completed, per customer request, over the next several months.
Implant Sciences' (IMSC) CEO Bill McGann on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu May 14, 6:31PM CDT
Implant Sciences Reports Third Quarter Fiscal 2015 Financial Results
PR Newswire - Thu May 14, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three and nine months ended March 31, 2015.
Implant Sciences Ships Additional $500,000 of Explosives Trace Detectors Worldwide
PR Newswire - Wed May 13, 11:29AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has continued its sales momentum, announcing the shipment of over $500,000 explosives trace detectors worldwide. These units, which include both the desktop QS-B220 explosives and drugs trace detector as well as the handheld QS-H150 explosives trace detector, will be used by customers for applications such as air cargo and critical infrastructure protection.
Implant Sciences Continues to Innovate - Granted Three More U.S. Patents for Trace Detection
PR Newswire - Mon May 11, 10:25AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the company has been granted three new patents by the U.S. Patent and Trademark Office.
Implant Sciences to Announce Third Quarter Fiscal 2015 Financial Results
PR Newswire - Fri May 08, 3:01PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company will host a webcast and conference call on Thursday, May 14, 2015 at 4:15 p.m. to discuss the financial results for the quarter ended March 31, 2015.
Major French Airport Selects Implant Sciences' ETDs
PR Newswire - Wed Apr 29, 11:30AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has received an order for 25 QS-B220 explosives trace detection systems from a major airport in France. The systems, which will be used to fulfill the recent European security regulations requirement for screening passengers and checked bags, are expected to be delivered in the Company's fourth fiscal quarter, ending June 30, 2015.
Implant Sciences Announces another Significant ECAC Win
PR Newswire - Tue Apr 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported that the Company has received an order for 75 QS-B220 explosives trace detection systems in the Netherlands. The systems are expected to be delivered in the Company's fourth fiscal quarter and will be used for screening passengers and baggage in an airport environment.
Implant Sciences Receives Order for 66 Explosives Trace Detection Systems in Norway
PR Newswire - Thu Apr 16, 9:52AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported that the Company has received an order for 66 QS-B220 explosives trace detection systems in Norway. The systems, many of which have already been shipped, are scheduled to be deployed for passenger and baggage screening in an airport environment.
Implant Sciences Announces Restructuring
PR Newswire - Wed Apr 15, 11:47AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced restructuring actions to better align costs with current and future geographic revenue sources and to improve efficiencies. The actions, which include increasing outreach and sales and marketing efforts, reducing expenses and other actions to align with our markets, are expected to result in a pre-tax charge of approximately $200,000 which will be recorded in the quarter ended March 31, 2015. The charge is primarily related to expenses incurred to relocate the San Diego, CA advanced technology office and costs related to closing our Shanghai office and converting our sales model in Southeast Asia from direct selling to in-country distribution. The Company expects the restructuring will result in annual pre-tax reductions of approximately $2 million in annual operating expenses, the benefits of which will begin in the fourth quarter of fiscal 2015, with the full savings expected to be achieved in fiscal 2016.
Implant Sciences' Executive Vice President Interviewed by Bloomberg TV about Boston Marathon Bombing Verdict
PR Newswire - Thu Apr 09, 11:45AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that Former Assistant Secretary for the Department of Homeland Security and Implant Sciences Corporation Executive Vice President, Robert Liscouski, was interviewed on Bloomberg TV about the Boston Marathon Bombing verdict. Mr. Liscouski discussed the vulnerabilities and potential for similar attacks in the future.
Implant Sciences Ships $500,000 Follow-On Order of QS-B220s to Kuehne + Nagel for U.S. Air Cargo Screening
PR Newswire - Wed Apr 08, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today it has shipped a follow-on order for approximately $500,000 of its QS-B220 explosives trace detectors to Kuehne + Nagel, one of the worlds' leading logistics companies. The QS-B220s will be deployed across a total of ten facilities for air cargo screening in the U.S. This order follows the customer's initial order in 2014.
Major International Airline in Latin America Adopts QS-B220
PR Newswire - Thu Mar 26, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of approximately $500,000 in explosives trace detection systems in Latin America, most of which were sold to a major international airline in Latin America.
Implant Sciences Ships $750,000 of Explosives Trace Detector Systems to Asia
PR Newswire - Mon Mar 23, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of more than $750,000 in explosives trace detection systems to various customers in Asia. The shipments include a mixture of QS-H150 and QS-B220 systems, and will be deployed in military, aviation security, and critical infrastructure protection applications.
Implant Sciences Announces Results of 2015 Annual Shareholder Meeting
PR Newswire - Tue Jul 07, 10:36AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it held its annual shareholders meeting on July 1, 2015 at its headquarters in Wilmington, MA. At this meeting, the company's shareholders approved each proposal presented, including the election of the Director nominees to the Board of Directors. The Board and Implant Sciences' management believes this outcome conveys investor confidence in the current direction of the company.
In the Latest in a Series of Wins, Finland Airports Select Implant Sciences' QS-B220
PR Newswire - Tue Jun 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 58 of its QS-B220 desktop explosives trace detectors to Finnish Airports. The systems are scheduled to be deployed within the next several months.
Implant Sciences' QS-B220 Wins GSN Award for "Best Security Checkpoint"
PR Newswire - Thu Jun 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced today its QS-B220 desktop explosives and drugs trace detector has won the 2015 GSN Airport/Seaport/Border Security Award for "Best Security Checkpoint" (persons, baggage, parcels). The QS-B220 was also a finalist in two other categories: "Best Explosives/Narcotics/Contraband Detection" and "Best Cargo/Vehicle Screening".
Up to 304 Additional QS-B220s Sold to French Airports as Implant Sciences Deepens its Foothold in EU
PR Newswire - Thu Jun 11, 8:30AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed a contract for up to 304 of its QS-B220 desktop explosives trace detectors across 17 regional airports in France. The first 106 units are committed to being delivered over the next several months. Additional units are expected to be delivered through fiscal year 2016 and 2017. The sale was made through the Company's in-country, full-service distributor, Hi-Tech Detection Systems (HTDS).
Four Major Airports in Poland Join Other European Airports in Selecting Implant Sciences' QS-B220 Trace Detectors to Meet European Security Regulations
PR Newswire - Thu Jun 04, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 16 of its QS-B220 desktop explosives trace detectors to four major international airports in Poland.
Implant Sciences Signs Deal for Up to $5 million with Ryan Security Technologies Ltd. to Expand Sales in China
PR Newswire - Mon Jun 01, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed an exclusive distribution agreement, worth up to $5 million, with Ryan Security Technologies Ltd. to manage sales and service of its products throughout all of China.
Another Major International European Airport Selects Implant Sciences' QS-B220
PR Newswire - Tue May 19, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 20 of its QS-B220 desktop explosives trace detectors into Belgium for aviation security. Shipment of these units is already underway and is expected to be completed, per customer request, over the next several months.
Implant Sciences' (IMSC) CEO Bill McGann on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu May 14, 6:31PM CDT
Implant Sciences Reports Third Quarter Fiscal 2015 Financial Results
PR Newswire - Thu May 14, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three and nine months ended March 31, 2015.
Implant Sciences Ships Additional $500,000 of Explosives Trace Detectors Worldwide
PR Newswire - Wed May 13, 11:29AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has continued its sales momentum, announcing the shipment of over $500,000 explosives trace detectors worldwide. These units, which include both the desktop QS-B220 explosives and drugs trace detector as well as the handheld QS-H150 explosives trace detector, will be used by customers for applications such as air cargo and critical infrastructure protection.
Implant Sciences Continues to Innovate - Granted Three More U.S. Patents for Trace Detection
PR Newswire - Mon May 11, 10:25AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the company has been granted three new patents by the U.S. Patent and Trademark Office.
Implant Sciences to Announce Third Quarter Fiscal 2015 Financial Results
PR Newswire - Fri May 08, 3:01PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company will host a webcast and conference call on Thursday, May 14, 2015 at 4:15 p.m. to discuss the financial results for the quarter ended March 31, 2015.
Major French Airport Selects Implant Sciences' ETDs
PR Newswire - Wed Apr 29, 11:30AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has received an order for 25 QS-B220 explosives trace detection systems from a major airport in France. The systems, which will be used to fulfill the recent European security regulations requirement for screening passengers and checked bags, are expected to be delivered in the Company's fourth fiscal quarter, ending June 30, 2015.
Implant Sciences Announces another Significant ECAC Win
PR Newswire - Tue Apr 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported that the Company has received an order for 75 QS-B220 explosives trace detection systems in the Netherlands. The systems are expected to be delivered in the Company's fourth fiscal quarter and will be used for screening passengers and baggage in an airport environment.
Implant Sciences Receives Order for 66 Explosives Trace Detection Systems in Norway
PR Newswire - Thu Apr 16, 9:52AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported that the Company has received an order for 66 QS-B220 explosives trace detection systems in Norway. The systems, many of which have already been shipped, are scheduled to be deployed for passenger and baggage screening in an airport environment.
Implant Sciences Announces Restructuring
PR Newswire - Wed Apr 15, 11:47AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced restructuring actions to better align costs with current and future geographic revenue sources and to improve efficiencies. The actions, which include increasing outreach and sales and marketing efforts, reducing expenses and other actions to align with our markets, are expected to result in a pre-tax charge of approximately $200,000 which will be recorded in the quarter ended March 31, 2015. The charge is primarily related to expenses incurred to relocate the San Diego, CA advanced technology office and costs related to closing our Shanghai office and converting our sales model in Southeast Asia from direct selling to in-country distribution. The Company expects the restructuring will result in annual pre-tax reductions of approximately $2 million in annual operating expenses, the benefits of which will begin in the fourth quarter of fiscal 2015, with the full savings expected to be achieved in fiscal 2016.
Implant Sciences' Executive Vice President Interviewed by Bloomberg TV about Boston Marathon Bombing Verdict
PR Newswire - Thu Apr 09, 11:45AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that Former Assistant Secretary for the Department of Homeland Security and Implant Sciences Corporation Executive Vice President, Robert Liscouski, was interviewed on Bloomberg TV about the Boston Marathon Bombing verdict. Mr. Liscouski discussed the vulnerabilities and potential for similar attacks in the future.
Implant Sciences Ships $500,000 Follow-On Order of QS-B220s to Kuehne + Nagel for U.S. Air Cargo Screening
PR Newswire - Wed Apr 08, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today it has shipped a follow-on order for approximately $500,000 of its QS-B220 explosives trace detectors to Kuehne + Nagel, one of the worlds' leading logistics companies. The QS-B220s will be deployed across a total of ten facilities for air cargo screening in the U.S. This order follows the customer's initial order in 2014.
Major International Airline in Latin America Adopts QS-B220
PR Newswire - Thu Mar 26, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of approximately $500,000 in explosives trace detection systems in Latin America, most of which were sold to a major international airline in Latin America.
Implant Sciences Ships $750,000 of Explosives Trace Detector Systems to Asia
PR Newswire - Mon Mar 23, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of more than $750,000 in explosives trace detection systems to various customers in Asia. The shipments include a mixture of QS-H150 and QS-B220 systems, and will be deployed in military, aviation security, and critical infrastructure protection applications.
